ASHP Midyear 2013
Stay tuned for The American Journal of Managed Care's conference coverage of the American Society of Health-System Pharmacists' Midyear Clinical Meeting in Orlando, FL, from December 8- 12. Make sure to sign up for our daily e-mail blasts on our registration page, and check back here during the conference for the full ASHP Midyear Clinical Meeting coverage.
Day 1
Colin Powell Addresses Health-System Pharmacists
Retired general and former secretary of state Colin Powell discussed his thoughts on the US healthcare system and the role pharmacists play within it during his keynote address at the ASHP Midyear Clinical Meeting.
Advanced Clinical Pharmacy Services Integration in an Accountable Care Organization
In this session, a sustainable business model for pharmacists practicing in an accountable care organization environment was described by Kelly Boesen, PharmD, BCPS, and Sandra Leal, PharmD, MPH, CDE, FAPhA, of the El Rio Health Center in Tucson, Arizona.
Newest Drugs of Abuse: Spice, Bath Salts, Salvia, and Beyond
llicit drug use continues to be a prevalent and growing problem in the United States, and the use of newer substances is on the rise. Because of the increasing prevalence and tweaking of compounds to avoid detection, the identification of drug abuse by practitioners often relies on signs and symptoms. In this session, presenters reviewed some of these agents, including their history and their impact on those abusing them.
Day 2
Healthcare Quality Measurement and Reporting: Experiences From the NQF
Quality and performance measurement has become an integral part of the healthcare system. As pharmacists continue to increase their role and exposure as healthcare providers, they are well positioned to assist in identifying ways to improve the quality of care delivered and to play an integral role in the development of quality measures, according to Curtis Collins, PharmD, MS, BCPS (AQ-ID), FASHP, who spoke at the ASHP Midyear Meeting.
The Ideal Clinical Practice: Myth or Reality
New and experienced pharmacists are always on the lookout for ways to improve their careers. This presentation focuses on some key strategies for identifying new opportunities that allow new and experienced pharmacists to develop and apply their clinical skills.
The Clinical Impact of Next-Generation Sequencing (NGS) on Pharmacy Practice
Genomic sequencing is rapidly increasing its value as a clinical tool in the diagnosis and treatment of many diseases, including cancer. In his presentation, Justin M. Balko, PharmD, PhD, from Vanderbilt University, provided a background on the current state of next-generation genomic sequencing (NGS), and the potential role that pharmacists play as this science continues to evolve.
Day 3
Pharmacists Make Progress Toward Attaining Provider Status
Speakers at the ASHP Midyear Clinical Meeting ranging from ASHP President Gerald Meyer, PharmD, to Michael Lee, PharmD, of the Indian Health Service, argued that pharmacists are closer than ever before to achieving their goal of attaining provider status.
Controlling the Obesity Epidemic: Where Does Pharmacy Weigh In?
As the prevalence of obesity continues to increase and treatment strategies evolve, pharmacists are not only in a position to advise on appropriate use of pharmacotherapy for obesity, but also to assist in improving outcomes from gastric bypass surgery.
Considerations for Constructing a Specialty Pharmacy Service Business Plan
Specialty pharmacy presents itself as both a challenging business model and a significant financial opportunity under the right circumstances, especially for health systems. Kevin Colgan, MA, FASHP, of Rush University Medical Center and Kyle Skiermont, PharmD, of Fairview Pharmacy Services provided an overview of specialty pharmacies and presented strategies for building a successful specialty pharmacy business.